Reviscon está indicado para el dolor de rodilla en pacientes con osteoartritis (OA) que no responden suficientemente al tratamiento farmacológico y analgésico simples (como el …

Reviscon® offers the most comprehensive and complete range of dosage forms and hyaluronic acid concentrations, adapted for different therapeutic needs in osteoarthritis treatment.

Reviscon Mono is an intra-articular injection with high molecular weight sodium hyaluronate to prevent pain and motion limitation for all joints caused by Osteoarthritis. Reviscon Mono …

VSY Biotechnology GmbH is pleased to announce that Health Canada has approved Reviscon Mono 2% (2.4 ml), a single-injection viscoelastic sodium hyaluronate solution designed to …

Reviscon Mono 2.0% is a viscoelastic sodium hyaluronate solution for intra-articular injection, presented in a 2.4 ml single-use glass syringe. Each milliliter of Reviscon Mono contains 20.0 …

All Reviscon products are intra-articular injections containing high molecular weight sodium hyaluronate to prevent pain and improve motion impairments for all joints caused by …

Reviscon Mono 2.0% conţine soluţie vâsco-elastică de 2.4 ml pentru injecţii monodoze, cu administrare intra-articulară. Reviscon Mono 2.0% este un produs cu efect analgezic, …

Reviscon ®, con un peso molecular de 3 MDa, es un hialuronato de sodio de alto peso molecular con cadenas de ingredientes activos más largas, proporcionando características únicas de …

Reviscon® offers the most comprehensive and complete range of dosage forms and hyaluronic acid concentrations, adapted for different therapeutic needs in osteoarthritis treatment.

Revsicon IA injections are a treatment for osteoarthritis of the II and III d egrees of the Kellgren Lawrence scale.